On June 13, 2019 Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune modulating antibodies, cancer vaccines, adjuvants and adoptive cell therapies1, reported investors and the general public to attend its annual meeting of stockholders on June 19, 2019 at 5:00 p.m. ET (Press release, Agenus, JUN 13, 2019, View Source [SID1234537058]). The meeting will be held at the Company’s headquarters located at 3 Forbes Road, Lexington, MA 02421. Registration for attendees will start at 4:30 p.m. ET.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Conference Call and Webcast Information:
Date: Wednesday, June 19, 2019
Time: 5:00 p.m. ET
Domestic Dial-in Number: 1-844-492-3727
International Dial-in Number: 1-412-317-5118
Conference ID: Agenus
Live Webcast: accessible from the Company’s website at View Source or with this link View Source
A replay will be available on the Company’s website approximately two hours after the call and will remain available for 90 days.